Literature DB >> 29760276

Early Blood-Brain Barrier Disruption in Ischemic Stroke Initiates Multifocally Around Capillaries/Venules.

Angelika Hoffmann1, Tassilo Dege2, Reiner Kunze3, Anne-Sophie Ernst3,4, Holger Lorenz5, Laura-Inés Böhler3,4, Thomas Korff3, Hugo H Marti3, Sabine Heiland2, Martin Bendszus2, Xavier Helluy3,6,7, Mirko Pham2,8.   

Abstract

BACKGROUND AND
PURPOSE: Detection and localization of the early phase of blood-brain barrier disruption (BBBD) in vivo during cerebral ischemia/reperfusion injury remain a major challenge but may be a relevant outcome parameter in stroke.
METHODS: We studied early BBBD in mice after transient middle cerebral artery occlusion by multimodal, high-field (9.4T) in vivo magnetic resonance imaging, including the contrast agent gadofluorineM as an albumin-binding tracer. GadofluorineM contrast-enhanced magnetic resonance imaging was performed to determine BBBD at 2, 6, and 24 hours after reperfusion. BBBD was confirmed and localized along the microvascular tree by using fluorescent gadofluorineM and immunofluorescence stainings (cluster of differentiation 31, ephrin type-B receptor 4, alpha smooth muscle actin, ionized calcium binding adaptor molecule 1).
RESULTS: GadofluorineM contrast-enhanced magnetic resonance imaging revealed a multifocal spatial distribution of early BBBD and its close association with the microvasculature at a resolution of 40 μm. GadofluorineM leakage was closely associated with ephrin type-B receptor 4-positive but not alpha smooth muscle actin-positive vessels. The multifocal pattern of early BBBD (already at 2 hours after reperfusion) thus occurred in the distal capillary and venular microvascular bed. These multifocal zones showed distinct imaging signs indicative of early vasogenic edema. The total volume of multifocal early BBBD accurately predicted infarct size at 24 hours after reperfusion.
CONCLUSIONS: Early BBBD in focal cerebral ischemia initiates multifocally in the distal capillary and venular bed of the cerebral microvasculature. It is closely associated with perimicrovascular vasogenic edema and microglial activation and predicts the extent of final infarction.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  biomarkers; blood–brain barrier; contrast media; ephrins; mice; microvessels; reperfusion injury

Mesh:

Year:  2018        PMID: 29760276     DOI: 10.1161/STROKEAHA.118.020927

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

Review 1.  PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.

Authors:  Zeinab Y Motawe; Salma S Abdelmaboud; Javier Cuevas; Jerome W Breslin
Journal:  Int J Biochem Cell Biol       Date:  2020-07-12       Impact factor: 5.085

Review 2.  Basement Membrane Changes in Ischemic Stroke.

Authors:  Minkyung Kang; Yao Yao
Journal:  Stroke       Date:  2020-03-03       Impact factor: 7.914

Review 3.  Role of Na+/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to pharmacology.

Authors:  Mengyuan Zhu; Haijian Sun; Lei Cao; Zhiyuan Wu; Bin Leng; Jinsong Bian
Journal:  J Mol Med (Berl)       Date:  2021-11-27       Impact factor: 4.599

4.  Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke.

Authors:  Feifei Ma; Ping Sun; Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  Sci Signal       Date:  2020-04-07       Impact factor: 8.192

Review 5.  Rapamycin in ischemic stroke: Old drug, new tricks?

Authors:  Gina Hadley; Daniel J Beard; Yvonne Couch; Ain A Neuhaus; Bryan A Adriaanse; Gabriele C DeLuca; Brad A Sutherland; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-18       Impact factor: 6.200

6.  Fluoxetine suppresses inflammatory reaction in microglia under OGD/R challenge via modulation of NF-κB signaling.

Authors:  Mouli Tian; Mei Yang; Zhenjie Li; Yiru Wang; Wei Chen; Liye Yang; Yonghua Li; Hongbin Yuan
Journal:  Biosci Rep       Date:  2019-04-26       Impact factor: 3.840

7.  CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.

Authors:  Yeomyeong Kim; Sungwoon Lee; Haiying Zhang; Sunghye Lee; Hyejeong Kim; Yeaji Kim; Moo-Ho Won; Young-Myeong Kim; Young-Guen Kwon
Journal:  J Neuroinflammation       Date:  2020-02-04       Impact factor: 8.322

8.  Single-Cell Microwell Platform Reveals Circulating Neural Cells as a Clinical Indicator for Patients with Blood-Brain Barrier Breakdown.

Authors:  Yu Zhang; Antony R Warden; Khan Zara Ahmad; Yanlei Liu; Xijun He; Minqiao Zheng; Xinlong Huo; Xiao Zhi; Yuqing Ke; Hongxia Li; Sijia Yan; Wenqiong Su; Deng Cai; Xianting Ding
Journal:  Research (Wash D C)       Date:  2021-07-08

Review 9.  Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.

Authors:  Jia Li; Meng Zheng; Olga Shimoni; William A Banks; Ashley I Bush; Jennifer R Gamble; Bingyang Shi
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

10.  Transient ocular surface non-perfusion during cataract phacoemulsification surgery.

Authors:  Yijun Hu; Wei Qi; Baoyi Liu; Honghua Yu
Journal:  BMC Ophthalmol       Date:  2020-07-31       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.